Nivolumab + ipilimumab

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Nivolumab + ipilimumab
Treatment and conditionWhere it standsTrials
Nivolumab + ipilimumab for head and neck neoplasmsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nivolumab + ipilimumab for neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nivolumab + ipilimumab for squamous cell carcinoma of head and neckPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1